Company intelligence / Profile preview

Artyc

Fremont, California, United Statesshipartyc.com ↗

Ownership: Private
Development stage: Commercial

Overview

Artyc has developed and commercialized battery-powered, reusable shippers for precision cold chain transport. Their Medstow Micro product enables decentralized clinical trials by allowing safe shipment of individual vials and patient samples with 72+ hour battery life. The company’s solutions reduce spoilage, emissions, and reliance on hazardous materials like dry ice while providing real-time monitoring of shipments. No clinical trial results apply as they do not develop therapeutics.

Modalities: Device (temperature-controlled shipping containers for biologics, gene therapies, and clinical samples)
Industry: Consumable Medical Devices

Partnerships

Not specifically listed in public sources as of June 2025. However, the company collaborates with hospitals, clinical trial sites, home-care teams, and has been recognized by the World Economic Forum Technology Pioneer program.

Beyond the preview

Go deeper on Artyc.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Artyc.

Explore the full profile